Efficient prophylaxis with defibrotide for hepatic veno-occlusive disease (VOD) after allogeneic stem cell transplantation (SCT).

被引：0
|
作者：
Chalandon, Y
Roosnek, E
Helg, C
Newton, A
Wacker, P
Chapuis, B
机构：
[1] Univ Hosp Geneva, Div Hematol, Geneva, Switzerland
[2] Univ Hosp Geneva, Div Immunol, Geneva, Switzerland
[3] Univ Hosp Geneva, Div Oncol, Geneva, Switzerland
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
411
引用
收藏
页码：111A / 111A
页数：1
相关论文
共 50 条
  • [1] Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation
    Chalandon, Y
    Roosnek, E
    Mermillod, B
    Newton, A
    Ozsahin, H
    Wacker, P
    Helg, C
    Chapuis, B
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (05) : 347 - 354
  • [2] Defibrotide prevent efficiently hepatic veno-occlusive disease after allogeneic stem cell transplantation in adult
    Chalandon, Y
    Roosnek, E
    Mermillod, B
    Helg, C
    Newton, A
    Chapuis, B
    BONE MARROW TRANSPLANTATION, 2003, 31 : S43 - S43
  • [3] Prophylactic defibrotide for the prevention of hepatic veno-occlusive disease (VOD) in hematopoietic stem cell transplantation (HSCT).
    Joshi, R
    Kerridge, I
    Grace, S
    Ethell, M
    Potter, M
    Prentice, HG
    BLOOD, 2002, 100 (11) : 413A - 414A
  • [4] Cost-Effectiveness of Defibrotide in the Prophylaxis of Veno-Occlusive Disease after Pediatric Allogeneic Stem Cell Transplantation
    Pichler, Herbert
    Homer, Karolina
    Engstler, Gernot
    Poetschger, Ulrike
    Glogova, Evgenia
    Karlhuber, Susanne
    Martin, Manuel
    Eibler, Werner
    Witt, Volker
    Holter, Wolfgang
    Matthes-Martin, Susanne
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (07) : 1128 - 1133
  • [5] Defibrotide as salvage therapy for hepatic veno-occlusive disease (VOD).
    Abecasis, M
    Ferreira, I
    Guimaraes, A
    Machado, A
    BONE MARROW TRANSPLANTATION, 1999, 23 : S222 - S222
  • [6] Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation
    Corbacioglu, Selim
    Kernan, Nancy
    Lehmann, Leslie
    Brochstein, Joel
    Revta, Carolyn
    Grupp, Stephan
    Martin, Paul
    Richardson, Paul G.
    EXPERT REVIEW OF HEMATOLOGY, 2012, 5 (03) : 291 - 302
  • [7] Defibrotide effectively prevents veno-occlusive disease of the liver (VOD) after allogeneic stem cell transplantation. An extended study.
    Chalandon, Yves
    Roosnek, Eddy
    Helg, Claudine
    Verholen, Frank
    Knipp, Sabine
    Ozsahin, Hulya
    Passweg, Jakob R.
    BLOOD, 2006, 108 (11) : 840A - 840A
  • [8] Prevention of veno-occlusive disease in hematopoietic stem cell transplantation due to defibrotide prophylaxis
    Hasenkamp, J
    Conradi, I
    Wulf, G
    Jung, W
    Truemper, L
    Glass, B
    BLOOD, 2004, 104 (11) : 322A - 323A
  • [9] Prophylaxis with defibrotide prevents veno-occlusive disease in stem cell transplantation after gemtuzumab ozogamicin exposure
    Versluys, B
    Bhattacharaya, R
    Steward, C
    Cornish, J
    Oakhill, A
    Goulden, N
    BLOOD, 2004, 103 (05) : 1968 - 1968
  • [10] Defibrotide Low-Dose Continuous Infusion After Allogeneic Stem Cell Transplantation as Prophylaxis for Veno-Occlusive Disease of the Liver
    Bonini, Alessandro
    Imovilli, Annalisa
    Ghirarduzzi, Angelo
    Silingardi, Mauro
    Pilia, Annalisa
    Gugliotta, Luigi
    Merli, Francesco
    BLOOD, 2010, 116 (21) : 1431 - 1431
12345